2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 91.440 | 82.790 | 88.348 | 90.031 | 118.536 | 154.664 | 40.118 | 33.225 | 61.361 | 137.101 |
Total Income - EUR | 92.261 | 85.665 | 94.555 | 91.461 | 128.484 | 157.848 | 80.799 | 44.150 | 126.431 | 106.920 |
Total Expenses - EUR | 69.832 | 75.040 | 100.086 | 120.723 | 99.003 | 121.622 | 106.317 | 91.595 | 163.806 | 112.478 |
Gross Profit/Loss - EUR | 22.429 | 10.624 | -5.530 | -29.262 | 29.481 | 36.226 | -25.518 | -47.445 | -37.374 | -5.558 |
Net Profit/Loss - EUR | 19.311 | 8.660 | -6.414 | -30.806 | 28.273 | 34.659 | -25.970 | -47.819 | -37.836 | -7.005 |
Employees | 2 | 3 | 4 | 6 | 7 | 8 | 6 | 6 | 5 | 4 |
Check the financial reports for the company - Biotherm Prod Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 53.381 | 45.581 | 36.955 | 31.734 | 29.133 | 20.606 | 10.537 | 5.886 | 4.292 | 22.931 |
Current Assets | 38.305 | 36.189 | 42.873 | 49.551 | 75.832 | 66.307 | 68.672 | 97.611 | 99.258 | 36.042 |
Inventories | 1.454 | 563 | 4.177 | 25.677 | 27.571 | 26.019 | 61.307 | 64.214 | 82.319 | 17.338 |
Receivables | 36.070 | 29.237 | 27.346 | 8.812 | 31.596 | 2.692 | 7.340 | 25.783 | 5.619 | 7.190 |
Cash | 781 | 6.389 | 11.349 | 15.061 | 16.665 | 37.596 | 25 | 7.614 | 11.320 | 11.514 |
Shareholders Funds | 17.090 | 21.137 | 14.014 | -17.029 | 13.632 | 24.846 | -50.460 | -97.160 | -135.671 | -142.265 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 69.320 | 56.360 | 65.980 | 96.325 | 90.413 | 61.985 | 125.017 | 200.656 | 239.222 | 201.599 |
Income in Advance | 5.276 | 4.273 | 3.194 | 2.121 | 1.083 | 82 | 4.652 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "1629 - 1629" | |||||||||
CAEN Financial Year |
1629
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Biotherm Prod Srl